Suchergebnisse - "Geretti, Anna Maria"

PubPharm (24)

1

A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study) : study protocol for a randomised trial

enthalten in: BMC infectious diseases | 2020

von Iwuji, C. | Churchill, D. | Bremner, S. | +7

2

An apparent paradox : resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Geretti, A. | Abdullahi, A. | Mafotsing Fopoussi, O. | +6

3

Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Villa, G. | Phillips, R. | Smith, C. | +7

4

Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa : A Systematic Review and Meta-analysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2018

von Stockdale, A. | Saunders, M. | Boyd, M. | +9

5

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data

enthalten in: AIDS research and therapy | 2018

von Stirrup, O. | Dunn, D. | Tostevin, A. | +109

6

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens : Cohort Study in the United Kingdom

enthalten in: The Journal of infectious diseases | 2016

von White, E. | Smit, E. | Churchill, D. | +65

CommentIn: J Infect Dis. 2016 Nov 1;214(9):1289-1291. - PMID 27869617

7

Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2016

von Noguera-Julian, M. | Cozzi-Lepri, A. | Di Giallonardo, F. | +32

8

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART : a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing

enthalten in: The Journal of antimicrobial chemotherapy | 2015

von Cozzi-Lepri, A. | Noguera-Julian, M. | Di Giallonardo, F. | +32

9

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

enthalten in: AIDS (London, England) | 2013

von Mackie, N. | Dunn, D. | Dolling, D. | +108

10

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors

enthalten in: The Journal of antimicrobial chemotherapy | 2013

von Koning, F. | Castro, H. | Dunn, D. | +40